| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/13/2011 | CN102014921A Composition for modulating stem cell growth with prostaglandins |
| 04/13/2011 | CN102014920A Eye-drop preparation and use thereof |
| 04/13/2011 | CN102014919A Methotrexate adjuvants to reduce toxicity and methods for using the same |
| 04/13/2011 | CN102014918A Pharmaceutical compositions prepared by trace precipitation |
| 04/13/2011 | CN102014917A Use of 2,4-pyrimidinediamines for the treatment of atherosclerosis |
| 04/13/2011 | CN102014916A 1-methylnicotinamide analogs |
| 04/13/2011 | CN102014915A Adenosine derivatives as partial and full agonists of A1 adenosine receptors |
| 04/13/2011 | CN102014914A 3H-[1,2,3]triazolo[4,5-D]pyrimidine compounds, their use as MTOR kinase and PI3 kinase inhibitors, and their syntheses |
| 04/13/2011 | CN102014913A Combination therapy with C-MET and EGFR antagonists |
| 04/13/2011 | CN102014912A Combination therapy 238 |
| 04/13/2011 | CN102014911A HCV NS3 protease inhibitors |
| 04/13/2011 | CN102014910A Methods, dosage forms, and kits for administering ziprasidone without food |
| 04/13/2011 | CN102014909A Solid preparation for oral administration |
| 04/13/2011 | CN102014908A Therapeutic uses of compounds having combined SERT, 5-HT3 and 5-HT1A activity |
| 04/13/2011 | CN102014907A Oral administration of peripherally-acting opioid antagonists |
| 04/13/2011 | CN102014906A Compositions for the treatment of vaginal infections with chronic inflammation |
| 04/13/2011 | CN102014905A Donepezil-containing patch preparation and packaging thereof |
| 04/13/2011 | CN102014904A Liquid formulation for deferiprone with palatable taste |
| 04/13/2011 | CN102014903A 5-hydroxymethyl-oxazolidin-2-one derivatives for treating bacterial intestinal diseases |
| 04/13/2011 | CN102014902A Inhibitors of checkpoint kinases |
| 04/13/2011 | CN102014901A Pharmaceutical composition |
| 04/13/2011 | CN102014900A Method of treating cancer using a neuropeptide Y5R (NPY5R) antagonist |
| 04/13/2011 | CN102014899A Process for the preparation of polymorphic forms of clopidogrel hydrogen sulfate |
| 04/13/2011 | CN102014898A Tetrazole compounds for reducing uric acid |
| 04/13/2011 | CN102014897A Compounds, compositions and methods for making the same |
| 04/13/2011 | CN102014896A Pharmaceutical composition comprising racetam and carnitine and process for its preparation |
| 04/13/2011 | CN102014895A Combination anti-cancer agents |
| 04/13/2011 | CN102014894A Improved statin production |
| 04/13/2011 | CN102014893A Polyphenols for the treatment of cartilage disorders |
| 04/13/2011 | CN102014892A Compositions for the treatment and prevention of infections of the oral cavity |
| 04/13/2011 | CN102014891A Compositions and methods of use of compounds to increase cancer patient survival time |
| 04/13/2011 | CN102014890A Therapeutic agent for male sterility |
| 04/13/2011 | CN102014889A Method of utilization of combination of benzophenone derivative or salt thereof and immunosuppressing agent, and pharmaceutical composition comprising these components |
| 04/13/2011 | CN102014888A New medical applications of alpha-ketoglutarate |
| 04/13/2011 | CN102014887A Antifolate agent combinations in the treatment of cancer |
| 04/13/2011 | CN102014884A Transdermal therapeutic system for administration of fentanyl or an analog thereof |
| 04/13/2011 | CN102014881A Pharmaceutical preparation |
| 04/13/2011 | CN102014877A Pharmaceutical dosage form |
| 04/13/2011 | CN102014870A Activated nitric oxide donors and methods of making and using thereof |
| 04/13/2011 | CN102014869A Ketorolac tromethamine compositions for treating or preventing ocular pain |
| 04/13/2011 | CN102014861A Moisturizing agent |
| 04/13/2011 | CN102014859A Novel compositions which inhibit melanogenesis and uses thereof |
| 04/13/2011 | CN102014635A Di-fluoro containing compounds as cysteine protease inhibitors |
| 04/13/2011 | CN102014632A Indoline anti-cancer agents |
| 04/13/2011 | CN102014631A Tyrosine kinase inhibitors |
| 04/13/2011 | CN102014627A Fused bicyclic pyrimidine compounds as aurora kinase inhibitors |
| 04/13/2011 | CN102014626A Steroidal ligands and their use in gene switch modulation |
| 04/13/2011 | CN102014625A Novel formulations for treatment of migraine |
| 04/13/2011 | CN102014624A Picoplatin and amrubicin to treat lung cancer |
| 04/13/2011 | CN102014623A Producing biofuels using polyketide synthases |
| 04/13/2011 | CN102010512A Preparation method and application of water-soluble chitosan micro-particles |
| 04/13/2011 | CN102010456A Method for extracting pseudoginsenoside RT5 and medical application |
| 04/13/2011 | CN102010454A Citicoline sodium compound and new method thereof |
| 04/13/2011 | CN102010453A Flavonol glycosides compound extracted from loropetalum chinense leaf and medicinal application thereof |
| 04/13/2011 | CN102010432A Cefodizime sodium compound and novel method thereof |
| 04/13/2011 | CN102010425A 1,4-disulfide-7-azaspiro [4,4] nonane-8-carboxylic acid derivative histone deacetylase inhibitor and application thereof |
| 04/13/2011 | CN102010424A Crystal form III of (S)-alpha, alpha-[(2-chlorphenyl)-(4,5,6,7-thiophane[3,2-c]pyridine-5-yl)-N'-(dimethyl)methylene] acethydrazide and preparation method thereof |
| 04/13/2011 | CN102010423A Crystal form II of (S)-alpha, alpha-[(2-chlorphenyl)-(4,5,6,7-tetrahydrothieno [3,2-c] pyridine-5-yl)]-N'-(dimethyl) methylene) acethydrazide and preparation method |
| 04/13/2011 | CN102010422A Guanidyl-containing artemisinin derivates and application thereof |
| 04/13/2011 | CN102010421A Artemisinin derivatives and application thereof |
| 04/13/2011 | CN102010420A [(10S)-9,10-dihydroartemisinine-10-oxyl]benzaldehyde semicarbazones (sulfur) series substances as well as preparation method and application thereof |
| 04/13/2011 | CN102010418A High-camptothecin compounds and use thereof as medicaments |
| 04/13/2011 | CN102010405A 4-(benzofuran-5-yl)-2-benzal aminothiazole and application of 4-(benzofuran-5-base)-2-benzal aminothiazole as antineoplastic agent |
| 04/13/2011 | CN102010398A Nitrogen-containing biphenyl compound, pharmaceutical composition containing compound, preparation methods and application of compound in HIV-1 resistance |
| 04/13/2011 | CN102010396A Cytospolides with anti-tumor and antibacterial activity |
| 04/13/2011 | CN102010384A Deuterated cyanophenyl thiazoles derivative for treating gout and hyperur icemia |
| 04/13/2011 | CN102010382A Benzo[d]isoxazol-3-ol daao inhibitors |
| 04/13/2011 | CN102010375A Rosuvastatin calcium compound with stable crystal form |
| 04/13/2011 | CN102010373A Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof |
| 04/13/2011 | CN102010366A 2,6-dichloro-5-fluoronicotinoyl fluorobenzene salicylamide compound as well as preparation and application thereof |
| 04/13/2011 | CN102010348A Salicylamide ester type derivative and preparation method and application thereof |
| 04/13/2011 | CN102010347A Biphenyl compound serving as antitumor medicament and preparation method thereof |
| 04/13/2011 | CN102010324A Aspirin-triggered lipid mediators |
| 04/13/2011 | CN102010298A Indene derivatives as pharmaceutical agents |
| 04/13/2011 | CN102008741A Anti-inflammation and tissue regeneration-promoting sanitary towel and manufacturing method thereof |
| 04/13/2011 | CN102008739A Solid refreshment agent |
| 04/13/2011 | CN102008734A Inclusion compound of alpha crystal imatinib and preparation method thereof |
| 04/13/2011 | CN102008733A Anti-tumor controlled release nanocomposite and preparation method thereof |
| 04/13/2011 | CN102008731A Preparation method of fluorocarbon nanometer medicine-carrying preparation using block copolymer as carrier |
| 04/13/2011 | CN102008727A Injection-purpose medicine composition for improving stability of ligustrazine medicine injection formulation and preparation method of injection-purpose medicine composition |
| 04/13/2011 | CN102008726A Dexiburofen amino acid salt-containing medicament for colds |
| 04/13/2011 | CN102008725A Application of human UTP14a expression inhibitor to preparation of cell proliferation inhibitor |
| 04/13/2011 | CN102008723A Compound preparation of diclofenac sodium and triptan medicines for treating migraine |
| 04/13/2011 | CN102008722A Compound preparation of naproxen and triptan drugs for treating migraine |
| 04/13/2011 | CN102008715A Antitumor MA-TNF alpha medicine composition and application thereof |
| 04/13/2011 | CN102008714A Ointment for promoting rapid healing of scabby chilblain |
| 04/13/2011 | CN102008712A Trandolapril-containing compound preparation for curing hypertension |
| 04/13/2011 | CN102008711A Compound preparation containing enalapril for treating hypertension |
| 04/13/2011 | CN102008710A Lisinopril-containing compound preparation for treating hypertension |
| 04/13/2011 | CN102008709A Moexipril-contained compound preparation for treating hypertension |
| 04/13/2011 | CN102008708A Ramipril-contained compound preparation for treating hypertension |
| 04/13/2011 | CN102008707A Quinapril-contained compound preparation for treating hypertension |
| 04/13/2011 | CN102008674A Plaster for treating herniated disk, hyperosteogeny and rheumatoid diseases and preparation method thereof |
| 04/13/2011 | CN102008662A Traditional Chinese medicine composition for treating constipation and preparation method thereof |
| 04/13/2011 | CN102008653A Saliva increasing mixture |
| 04/13/2011 | CN102008633A Medicinal capsules for treating gastric ulcer, duodenal ulcer and gastritis |
| 04/13/2011 | CN102008630A Burn cream of camellia oil aloe |
| 04/13/2011 | CN102008628A Medicament for treating female genital tract virus infection and preparation method of sustained-release preparation of medicament |
| 04/13/2011 | CN102008625A Medicine for treating tuberculous lymphadenitis and preparation method thereof |
| 04/13/2011 | CN102008618A Externally used plaster for treating ulcers and bone diseases and preparation method thereof |